This was the stock's second consecutive day of losses.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

PGIM Jennison Health Sciences Fund released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 1500 Health Care Index returned 5.5% in the first quarter, ...

Nichols & Pratt Advisers sold 7,627 CVS Health shares in Q1, lowering its stake by 6.9%, SEC filings show. The firm now holds ...

Mirae Asset Global Investments Co. Ltd. juiced up its stake in CVS Health Corporation by a healthy 12.6%, showcasing a robust ...

These three dividend stocks provide investors with sizable yields and also produced market-beating gains in the first half of ...

In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, ...

Is CVS Health stock a buy? After today's rebound, CVS Health stock is up more than 50% year to date. Is the stock a buy? Income investors could like the stock with its forward dividend yield of 3.85%.

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.